Michael McAuliff

Seeking to Kick-Start Biden’s Agenda, Schumer Unveils a Bill for Medicare Drug Price Negotiations

KHN Original

In addition to allowing federal officials to negotiate the price that Medicare pays for some drugs, the bill would cap annual out-of-pocket drug costs for Medicare beneficiaries at $2,000. But before Democrats can pass the bill under special rules that prevent Republicans from staging a filibuster, they must get approval from the Senate parliamentarian.

Senate GOP Puts Up Roadblocks to Bipartisan House Bill for Veterans’ Burn Pit Care

KHN Original

The Senate could start work this week on a bipartisan bill to make it much easier for veterans to get health care and benefits if they get sick from exposure to massive, open-air incineration pits in war zones. The legislation has gained minimal support among Senate Republicans, who say they are concerned about the cost and the ability of Veterans Affairs to handle such a large new mission.

Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say

KHN Original

The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.